靶向RNA测序对儿童B-其他型急性淋巴细胞白血病的分类及遗传学特征
该研究采用靶向RNA测序对144例B-其他型和40例「经典」急性淋巴细胞白血病样本进行分型,通过融合转录本、异常表达、剪接位点及单核苷酸变异分析,进一步将66.7%(96/144)的B-其他型病例归类,并描述了各亚型与临床特征的相关性。
要点
- 靶向RNA测序可识别TCF3-PBX1、ETV6-RUNX1、KMT2A重排、BCR-ABL1及多种新型融合。
- CRLF2高表达与初诊白细胞≥50×10³/μL及GATA3风险等位基因相关。
- ABL/JAK2/EPOR融合与高白细胞、NCI高危分类及IKZF1缺失相关。
核心结论
- 靶向RNA测序进一步对66.7%(96/144)的B-其他型急性淋巴细胞白血病病例进行了分类。
- 除iAMP21、超二倍体和低二倍体外,所有BCP-ALL亚型均可被识别。
研究设计与样本
- 研究采用靶向RNA测序对144例B-其他型和40例「经典」急性淋巴细胞白血病样本进行分析。
主要发现
- 经典TCF3-PBX1、ETV6-RUNX1、KMT2A重排和BCR-ABL1,以及新型P2RY8-CRLF2、ABL、JAK2、ZNF384、MEF2D和NUTM1融合可通过融合转录本分析识别。
- IGH-CRLF2和IGH-EPOR通过CRLF2或EPOR表达水平异常升高发现。
- DUX4重排通过DUX4基因异常表达和ERG替代外显子或基因表达聚类分析识别。
- PAX5驱动型ALL(包括融合、基因内扩增和突变)通过单核苷酸变异分析和IGV软件人工检查识别,外显子连接分析可检测部分ERG和IKZF1基因内缺失。
- CRLF2高表达与初诊白细胞计数≥50×10³/μL及GATA3风险等位基因(rs3781093和rs3824662)相关;ABL/JAK2/EPOR融合与高白细胞计数、美国国家癌症研究所高危分类及IKZF1缺失相关;ZNF384融合与CALLA阴性相关;NUTM1融合见于婴儿。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute lymphoblastic leukemia (ALL) can be classified into different subgroups based on recurrent genetic alterations. Here, targeted RNA sequencing was used to identify the novel subgroups of ALL in 144 B-other and 40 "classical" ALL samples. The classical TCF3-PBX1, ETV6-RUNX1, KMT2A-rearranged, and BCR-ABL1, and novel P2RY8-CRLF2, ABL-, JAK2-, ZNF384-, MEF2D-, and NUTM1-fusions were easily identified by fusion transcript analysis. IGH-CRLF2 and IGH-EPOR were found by abnormally high levels of expression of CRLF2 or EPOR. DUX4-rearranged was identified by the unusual expression of DUX4 genes and an alternative exon of ERG, or by clustering analysis of gene expression. PAX5-driven ALL, including fusions, intragenic amplifications, and mutations were identified by single-nucleotide variant analysis and manual inspection using the IGV software. Exon junction analysis allowed detection of some intragenic ERG and IKZF1 deletions. CRLF2-high associated with initial white blood cell (WBC) counts of ≥50 × 103/μL and GATA3 risk alleles (rs3781093 and rs3824662), whereas ABL/JAK2/EPOR-fusions associated with high WBC counts, National Cancer Institute's high-risk classification, and IKZF1del. ZNF384-fusions associated with CALLA-negativity and NUTM1-fusions in infants. In conclusion, targeted RNA sequencing further classified 66.7% (96 of 144) B-other ALL cases. All BCP-ALL subgroups, except for iAMP21, hyperdiploid and hypodiploid cases, were identified. Curiously, we observed higher frequencies of females within B-rest ALLs and males in PAX5-driven cases.
引用
- Migita NA, Jotta PY, Nascimento NPD, et al. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing. Blood Adv. 2023. PMID: 36848637. doi:10.1182/bloodadvances.2022009179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。